Share Facebook Twitter LinkedIn Pinterest Email Correction: Co-delivery of axitinib and PD-L1 siRNA for the synergism of vascular normalization and immune checkpoint Inhibition to boost anticancer immunity Source link axitinib Biotechnology Codelivery correction Molecular Medicine Nanotechnology PDL1 SiRNA synergism
